Who is sponsoring NCT05992779?

NCT05992779 is sponsored by Hospices Civils de Lyon.

What drugs are being tested in NCT05992779?

Interventions in NCT05992779: Measuring the vocal audiometry of patients., Measuring data loging.

What condition does NCT05992779 study?

NCT05992779 studies Cochlear, Implant.

Is NCT05992779 still recruiting?

NCT05992779 is currently status unknown. Last updated 15 August 2023.

Last reviewed 2023-08-15 · How we verify

NCT05992779: RCIVELDO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cochlear Implantation in the Elderly

Status unknown Last updated 15 August 2023

What this trial tests

trial testing Measuring the vocal audiometry of patients. in Cochlear in 150 participants. Status unknown.

Timeline

3 April 2023

Primary endpoint
3 May 2023

31 October 2023

Quick facts

Lead sponsor	Hospices Civils de Lyon
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	3 April 2023
Primary completion	3 May 2023
Estimated completion	31 October 2023
Sites	1 location across France

Drugs / interventions tested

Measuring the vocal audiometry of patients.
Measuring data loging

Conditions studied

Cochlear — all drugs for Cochlear →
Implant — all drugs for Implant →

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

80 and older, any sex, with Cochlear or Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to demonstrate that cochlear implantation is an effective, reasonable, and viable long-term option within a very elderly population

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05992779 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
Last refreshed: 15 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05992779.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing